Inactive Instrument

Company Kyto Biopharma Inc Other OTC

Equities

US5015721013

Financial & Commodity Market Operators

Business Summary

Kyto Technology and Life Science, Inc. is an investment company focused on creating an exchange-traded fund (ETF)-like vehicle of diversified and thoroughly vetted start-ups thus defining an entirely new non-correlated asset class. The Company’s portfolio includes AbFero Pharmaceuticals Inc., Achelios Therapeutics, Inc., Altis Biosystems, AmplifiDX, AOA Inc., Astrocyte Pharmaceuticals Inc. and other.

Managers

Managers TitleAgeSince
Chief Executive Officer 81 05/99/05
Director of Finance/CFO 75 15/18/15
Investor Relations Contact - 01/19/01
Corporate Officer/Principal 76 -
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 81 05/99/05
Director/Board Member 72 08/21/08
Director/Board Member 88 08/21/08
Director/Board Member - 08/21/08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 13,287,621 7,124,701 ( 53.62 %) 0 53.62 %
Stock B 0 4,200,000 0 0

Shareholders

NameEquities%Valuation
12,500 2.273 % 28 125 $

Company contact information

Kyto Technology & Life Science, Inc.

13050 La Paloma Road

94022, Los Altos Hills

+

http://www.kytotech.com
address Kyto Biopharma Inc
  1. Stock Market
  2. Equities
  3. KBPH Stock
  4. Stock
  5. Company Kyto Biopharma Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW